Literature DB >> 17719550

Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling.

Takuji Iwasato1, Hironori Katoh, Hiroshi Nishimaru, Yukio Ishikawa, Haruhisa Inoue, Yoshikazu M Saito, Reiko Ando, Mizuho Iwama, Ryosuke Takahashi, Manabu Negishi, Shigeyoshi Itohara.   

Abstract

The ephrin/Eph system plays a central role in neuronal circuit formation; however, its downstream effectors are poorly understood. Here we show that alpha-chimerin Rac GTPase-activating protein mediates ephrinB3/EphA4 forward signaling. We discovered a spontaneous mouse mutation, miffy (mfy), which results in a rabbit-like hopping gait, impaired corticospinal axon guidance, and abnormal spinal central pattern generators. Using positional cloning, transgene rescue, and gene targeting, we demonstrated that loss of alpha-chimerin leads to mfy phenotypes similar to those of EphA4(-/-) and ephrinB3(-/-) mice. alpha-chimerin interacts with EphA4 and, in response to ephrinB3/EphA4 signaling, inactivates Rac, which is a positive regulator of process outgrowth. Moreover, downregulation of alpha-chimerin suppresses ephrinB3-induced growth cone collapse in cultured neurons. Our findings indicate that ephrinB3/EphA4 signaling prevents growth cone extension in motor circuit formation via alpha-chimerin-induced inactivation of Rac. They also highlight the role of a Rho family GTPase-activating protein as a key mediator of ephrin/Eph signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719550     DOI: 10.1016/j.cell.2007.07.022

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  75 in total

1.  Rho/RacGAPs: embarras de richesse?

Authors:  Roland Csépányi-Kömi; Magdolna Lévay; Erzsébet Ligeti
Journal:  Small GTPases       Date:  2012-07-01

Review 2.  Cellular responses to extracellular guidance cues.

Authors:  Anastacia Berzat; Alan Hall
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

Review 3.  Signaling from axon guidance receptors.

Authors:  Greg J Bashaw; Rüdiger Klein
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-24       Impact factor: 10.005

Review 4.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 5.  Harnessing activity-dependent plasticity to repair the damaged corticospinal tract in an animal model of cerebral palsy.

Authors:  John H Martin; Samit Chakrabarty; Kathleen M Friel
Journal:  Dev Med Child Neurol       Date:  2011-09       Impact factor: 5.449

6.  Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.

Authors:  Jonathan W Astin; Jennifer Batson; Shereen Kadir; Jessica Charlet; Raj A Persad; David Gillatt; Jon D Oxley; Catherine D Nobes
Journal:  Nat Cell Biol       Date:  2010-11-14       Impact factor: 28.824

Review 7.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

8.  Variable laterality of corticospinal tract axons that regenerate after spinal cord injury as a result of PTEN deletion or knock-down.

Authors:  Rafer Willenberg; Katherine Zukor; Kai Liu; Zhigang He; Oswald Steward
Journal:  J Comp Neurol       Date:  2016-03-09       Impact factor: 3.215

Review 9.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

10.  The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.

Authors:  Melany J Wagner; Marilyn S Hsiung; Gerald D Gish; Rick D Bagshaw; Sasha A Doodnauth; Mohamed A Soliman; Claus Jørgensen; Monika Tucholska; Robert Rottapel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.